Stories

 {Photo Credit: Warren Zelman}A mother holds her newborn at a hospital in Mwene-Ditu, Democratic Republic of the CongoPhoto Credit: Warren Zelman

By Kimberly Whipkey, Advocacy Manager, White Ribbon AllianceThis story was originally published by the White Ribbon AllianceNearly five years into the Sustainable Development Goal (SDG) era, maternal mortality rates worldwide are still unacceptably high. Why?It’s not for a lack of technical know-how.

Unable to work, Rasel worried about how his family would survive while he went through treatment for drug-resistant TB.Photo credit: Challenge TB Bangladesh

Bangladesh is a global hotspot for TB, and the country’s government and its partners are hard at work to find and treat missing cases of TB and prevent the spread of multidrug-resistant TB (MDR-TB). The available treatment for MDR-TB is expensive, lengthy, and complex, and the disease is often considered a death sentence.

One of the first patients in Bangladesh to receive the shorter treatment regimen, Billal survived multi-drug resistant TB and returned to his life and his family.Photo credit: Challenge TB Bangladesh

Living with TB is very hard, and living with drug-resistant TB (DR-TB) is even worse. The drugs needed to treat DR-TB are not only toxic but also very expensive, and treatment can take as long as two years to complete. In April 2017, with the support of USAID’s Challenge TB (CTB) project, Bangladesh started its first patients on a shorter treatment regimen for DR-TB.

Pages